inspectors – Pharma GMP

Stability vs Hold Time: What Inspectors Expect You to Show

digi — Mon, 24 Nov 2025 23:18:42 +0000

Stability vs Hold Time: What Inspectors Expect You to Show Stability vs Hold Time: Understanding Regulatory Expectations for Manufacturing Controls Pharmaceutical manufacturing operations are heavily regulated to ensure product quality, safety, and efficacy. One critical aspect of compliance within batch control and manufacturing is the management of stability and hold time studies. Regulatory agencies such...

Common Sampling Plan Deficiencies Noted by FDA Inspectors

digi — Mon, 24 Nov 2025 21:45:42 +0000

Common Sampling Plan Deficiencies Noted by FDA Inspectors Step-by-Step Guide to Identifying and Correcting Common Sampling Plan Deficiencies Noted by FDA Inspectors In pharmaceutical manufacturing, especially in the production of tablets, robust and compliant in-process sampling plans are essential for ensuring product quality and regulatory adherence. Across jurisdictions such as the US, UK, and EU,...

How to Document Line Clearance to Satisfy FDA and MHRA Inspectors

digi — Mon, 24 Nov 2025 19:09:42 +0000

How to Document Line Clearance to Satisfy FDA and MHRA Inspectors Step-by-Step Guide on How to Document Line Clearance to Satisfy FDA and MHRA Inspectors Line clearance is a critical step in pharmaceutical manufacturing designed to prevent product contamination, cross-contamination, and mix-ups before the start of a new batch. Proper documentation of line clearance activities...

How to Justify In-Process Control Frequency to FDA and EU Inspectors

digi — Mon, 24 Nov 2025 18:51:42 +0000

How to Justify In-Process Control Frequency to FDA and EU Inspectors Step-by-Step Guide to Justify In-Process Control Frequency for Tablet Manufacturing In the pharmaceutical industry, in-process controls (IPCs) are essential checkpoints to ensure product quality during manufacturing. Regulatory bodies such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the...

How to Justify In-Process Control Frequency to FDA and EU Inspectors

digi — Mon, 24 Nov 2025 18:51:42 +0000

How to Justify In-Process Control Frequency to FDA and EU Inspectors Step-by-Step Guide on How to Justify In-Process Control Frequency to FDA and EU Inspectors In pharmaceutical manufacturing, ensuring product quality through effective in-process controls (IPCs) is a regulatory requirement enforced by agencies such as the FDA, EMA, and MHRA. One critical aspect for manufacturing,...